Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cellsTetsuro Yoshimaru, Toyomasa Katagiri|Nature Communications|2013Cited by 80
Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactionsTetsuro Yoshimaru, Toyomasa Katagiri|Scientific Reports|2014Cited by 74
A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cellsTetsuro Yoshimaru, Toyomasa Katagiri|Nature Communications|2017Cited by 23
Therapeutic advances in<scp>BIG</scp>3‐<scp>PHB</scp>2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancerTetsuro Yoshimaru, Toyomasa Katagiri|Cancer Science|2015Cited by 15
Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeuticsTetsuro Yoshimaru, Toyomasa Katagiri|Scientific Reports|2017Cited by 13